Acadia Healthcare Reports 28.3% Growth in Fourth Quarter Adjusted EPS to $0.59 on Revenue of $495.3 Million

Go back to Acadia Healthcare Reports 28.3% Growth in Fourth Quarter Adjusted EPS to $0.59 on Revenue of $495.3 Million

Acadia (ACHC) Should Be Bought on CMA Enforcement Order Weakness - Mizuho

February 18, 2016 12:19 PM EST

Mizuho Securities analyst Ann Hynes said reaction in Acadia Healthcare (NASDAQ: ACHC) to CMA enforcement order is overdone and they would be buyers on weakness.

Hynes commented, "The U.K.'s Competition and Markets Authority (CMA) served an initial enforcement order relating to... More

Acadia Healthcare (ACHC) PT, Estimates Cut at Jefferies

February 17, 2016 6:51 AM EST

Jefferies analyst Brian Tanquilut lowered his price target on Acadia Healthcare (NASDAQ: ACHC) to $85.00 (from $100.00) but maintained a Buy rating.

Tanquilut commented, "Our thesis on ACHC (strong organic growth boosted by M&A, with optionality for Medicaid-driven upside) was further validated by... More

Acadia Healthcare (ACHC) Reports In-Line Q4 EPS, Offers Q1 & FY Guidance

February 16, 2016 4:14 PM EST

Acadia Healthcare (NASDAQ: ACHC) reported Q4 EPS of $0.59, in-line with the analyst estimate of $0.59. Revenue for the quarter came in at $495.3 million versus the consensus estimate of $488 million.

GUIDANCE:

Acadia Healthcare sees Q1 2016 EPS of $0.53-$0.54, versus the consensus of... More